Theravance Biopharma (TBPH) FCF Margin Growth (3y) (2016 - 2026)
Theravance Biopharma (TBPH) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
53,075.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
53,075.00 |
| Dec 31, 2025 |
82,438.00 |
| Sep 30, 2025 |
14,790.00 |
| Jun 30, 2025 |
92,513.00 |
| Mar 31, 2025 |
133,245.00 |
| Dec 31, 2024 |
28,106.00 |
| Sep 30, 2024 |
32,143.00 |
| Jun 30, 2024 |
35,804.00 |
| Mar 31, 2024 |
49,476.00 |
| Dec 31, 2023 |
34,456.00 |
| Sep 30, 2023 |
41,718.00 |
| Jun 30, 2023 |
27,458.00 |
| Mar 31, 2023 |
362,028.00 |
| Dec 31, 2022 |
-82,131.00 |
| Sep 30, 2022 |
17,923.00 |
| Jun 30, 2022 |
-4,079.00 |
| Mar 31, 2022 |
49,113.00 |
| Dec 31, 2021 |
5,421.00 |
| Sep 30, 2021 |
4,379.00 |
| Jun 30, 2021 |
-12,247.00 |
